Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Der Radiologe
|
November 12, 2005
[Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?]
K Wasser, S K Klein, H Junkermann, et al.
International Journal of Cancer
|
February 8, 1995
Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer
P Dall, K H Heider, H P Sinn, et al.
European Radiology
|
May 24, 2003
Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy
K Wasser, H P Sinn, C Fink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
J Heil, H M Kuerer, A Pfob, et al.
Intensive Care Medicine
|
November 1, 1996
Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat
J Schmidt, K Huch, K Mithöfer, et al.
International Journal of Cancer
|
March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
T Schilling, J Bürck, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2010
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
A Schneeweiss, F Marmé, A Ruiz, et al.
International Journal of Cancer
|
June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients
A Seute, H P Sinn, R F Schlenk, et al.
The Journal of Pathology
|
December 18, 2001
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns
W Boecker, H Buerger, K Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
A Schneeweiss, J Huober, H-P Sinn, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Der Radiologe
|
November 12, 2005
[Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?]
K Wasser, S K Klein, H Junkermann, et al.
International Journal of Cancer
|
February 8, 1995
Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer
P Dall, K H Heider, H P Sinn, et al.
European Radiology
|
May 24, 2003
Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy
K Wasser, H P Sinn, C Fink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
J Heil, H M Kuerer, A Pfob, et al.
Intensive Care Medicine
|
November 1, 1996
Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat
J Schmidt, K Huch, K Mithöfer, et al.
International Journal of Cancer
|
March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
T Schilling, J Bürck, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2010
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
A Schneeweiss, F Marmé, A Ruiz, et al.
International Journal of Cancer
|
June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients
A Seute, H P Sinn, R F Schlenk, et al.
The Journal of Pathology
|
December 18, 2001
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns
W Boecker, H Buerger, K Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
A Schneeweiss, J Huober, H-P Sinn, et al.
Page
of 8